These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 19026581)
1. [Study of 206 transfused sickle cell disease patients: immunization, transfusion safety and red blood cell supply]. Meunier N; Rodet M; Bonin P; Chadebech P; Chami B; Lee K; Habibi A; Bachir D; Galactéros F; Bierling P; Noizat-Pirenne F Transfus Clin Biol; 2008 Dec; 15(6):377-82. PubMed ID: 19026581 [TBL] [Abstract][Full Text] [Related]
2. Red cell exchange does not appear to increase the rate of allo- and auto-immunization in chronically transfused children with sickle cell disease. Venkateswaran L; Teruya J; Bustillos C; Mahoney D; Mueller BU Pediatr Blood Cancer; 2011 Aug; 57(2):294-6. PubMed ID: 21298771 [TBL] [Abstract][Full Text] [Related]
3. Partial C antigen in sickle cell disease patients: clinical relevance and prevention of alloimmunization. Tournamille C; Meunier-Costes N; Costes B; Martret J; Barrault A; Gauthier P; Galactéros F; Nzouékou R; Bierling P; Noizat-Pirenne F Transfusion; 2010 Jan; 50(1):13-9. PubMed ID: 19778340 [TBL] [Abstract][Full Text] [Related]
4. Red blood cell alloimmunization and minor red blood cell antigen phenotypes in transfused Ghanaian patients with sickle cell disease. Boateng LA; Campbell AD; Davenport RD; Osei-Akoto A; Hugan S; Asamoah A; Schonewille H Transfusion; 2019 Jun; 59(6):2016-2022. PubMed ID: 30758856 [TBL] [Abstract][Full Text] [Related]
5. [Sickle cell anemia and transfusion safety in Bamako, Mali. Seroprevalence of HIV, HBV and HCV infections and alloimmunization belonged to Rh and Kell systems in sickle cell anemia patients]. Diarra AB; Guindo A; Kouriba B; Dorie A; Diabaté DT; Diawara SI; Fané B; Touré BA; Traoré A; Gulbis B; Diallo DA Transfus Clin Biol; 2013 Dec; 20(5-6):476-81. PubMed ID: 23916574 [TBL] [Abstract][Full Text] [Related]
6. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Cox JV; Steane E; Cunningham G; Frenkel EP Arch Intern Med; 1988 Nov; 148(11):2485-9. PubMed ID: 3142382 [TBL] [Abstract][Full Text] [Related]
7. Red cell alloantibodies in patients with haemoglobinopathies. Hmida S; Mojaat N; Maamar M; Bejaoui M; Mediouni M; Boukef K Nouv Rev Fr Hematol (1978); 1994 Oct; 36(5):363-6. PubMed ID: 7892131 [TBL] [Abstract][Full Text] [Related]
8. Relevance of RH variants in transfusion of sickle cell patients. Noizat-Pirenne F; Tournamille C Transfus Clin Biol; 2011 Dec; 18(5-6):527-35. PubMed ID: 22024128 [TBL] [Abstract][Full Text] [Related]
9. Red Blood Cell Antigen Genotyping for Sickle Cell Disease, Thalassemia, and Other Transfusion Complications. Fasano RM; Chou ST Transfus Med Rev; 2016 Oct; 30(4):197-201. PubMed ID: 27345938 [TBL] [Abstract][Full Text] [Related]
10. Delayed hemolytic transfusion reaction due to anti-Go(a), an antibody against the low-prevalence Gonzales antigen. Larson PJ; Lukas MB; Friedman DF; Manno CS Am J Hematol; 1996 Dec; 53(4):248-50. PubMed ID: 8948664 [TBL] [Abstract][Full Text] [Related]
11. Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing. Matteocci A; Pierelli L Vox Sang; 2014 Apr; 106(3):197-208. PubMed ID: 24117723 [TBL] [Abstract][Full Text] [Related]
12. Red cell alloimmunisation in regularly transfused beta thalassemia patients in Pakistan. Zaidi U; Borhany M; Ansari S; Parveen S; Boota S; Shamim I; Zahid D; Shamsi T Transfus Med; 2015 Apr; 25(2):106-10. PubMed ID: 25870030 [TBL] [Abstract][Full Text] [Related]